Literature DB >> 7739308

Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin.

J P Power1, E Lawlor, F Davidson, E C Holmes, P L Yap, P Simmonds.   

Abstract

In a retrospective investigation of possible transmission of hepatitis C virus (HCV) by anti-rhesus D immunoglobulin (anti-D) in 1977, we compared variants infecting anti-D recipients in Ireland of one of the implicated batches with those of epidemiologically unrelated HCV-infected individuals. All 100 of the recipients of the batch investigated to date were infected with a single genotype (type 1), consistent with a single-source outbreak, whereas a wider range of genotypes (1, 2, and 3) were found in anti-HCV positive individuals from Ireland infected by different routes. Nucleotide sequences from a 222 base fragment from the NS-5 region of the genome amplified from stored aliquots of the implicated batch closely matched those detected in anti-D recipients 17 years after the transmission event. This study shows the value of molecular epidemiological techniques for identifying distant sources of infection, and for the epidemiological investigation of the current distribution and transmission of HCV in different populations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7739308     DOI: 10.1016/s0140-6736(95)91993-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  26 in total

1.  Genetic archaeology and the origins of the Irish population.

Authors:  D T Croke
Journal:  Ir J Med Sci       Date:  2000 Oct-Dec       Impact factor: 1.568

2.  Hepatitis C virus genotyping based on 5' noncoding sequence analysis (Trugene).

Authors:  P Halfon; P Trimoulet; M Bourliere; H Khiri; V de Lédinghen; P Couzigou; J M Feryn; P Alcaraz; C Renou; H J Fleury; D Ouzan
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

Review 3.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

4.  Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort.

Authors:  J McAllister; C Casino; F Davidson; J Power; E Lawlor; P L Yap; P Simmonds; D B Smith
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Nosocomial transmission of hepatitis C virus.

Authors:  R Schvarcz; B Johansson; B Nyström; A Sönnerborg
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

Review 6.  The quasispecies nature and biological implications of the hepatitis C virus.

Authors:  Sarah L Fishman; Andrea D Branch
Journal:  Infect Genet Evol       Date:  2009-08-08       Impact factor: 3.342

7.  Prenatal RhD Testing: A Review of Studies Published from 2006 to 2008.

Authors:  Tobias Jörg Legler; Sina Patricia Müller; Alexander Haverkamp; Simon Grill; Sinuhe Hahn
Journal:  Transfus Med Hemother       Date:  2009-05-14       Impact factor: 3.747

8.  Use of phylogenetic analysis of hepatitis C virus (HCV) hypervariable region 1 sequences to trace an outbreak of HCV in an autodialysis unit.

Authors:  Philippe Halfon; Christa Roubicek; Victoria Gerolami; Yves Quentin; Hacene Khiri; Gérad Pepe; Yvon Berland
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

9.  Human anti-rhesus D IgG1 antibody produced in transgenic plants.

Authors:  Thomas Bouquin; Mads Thomsen; Leif Kofoed Nielsen; Trine Hefsgaard Green; John Mundy; Morten Hanefeld Dziegiel
Journal:  Transgenic Res       Date:  2002-04       Impact factor: 2.788

10.  Use of the minimum spanning tree model for molecular epidemiological investigation of a nosocomial outbreak of hepatitis C virus infection.

Authors:  Enea Spada; Luciano Sagliocca; John Sourdis; Anna Rosa Garbuglia; Vincenzo Poggi; Carmela De Fusco; Alfonso Mele
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.